Stay updated on SAR442720 Combo Study in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the SAR442720 Combo Study in Advanced Malignancies Clinical Trial page.

Latest updates to the SAR442720 Combo Study in Advanced Malignancies Clinical Trial page
- Check3 days agoChange DetectedVersion bumped to v3.0.2. The 'Back to Top' control was removed; no substantive content changes.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific drug information for Pembrolizumab and Adagrasib, as well as detailed location data for various regions in South Korea, Chile, and Argentina. Notably, the facility name and location details have been revised to reflect the latest information.SummaryDifference2%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.5%
Stay in the know with updates to SAR442720 Combo Study in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR442720 Combo Study in Advanced Malignancies Clinical Trial page.